PHARMACEUTICAL COMPOSITIONS COMPRISING A HMG COA REDUCTASE INHIBITOR
Application 1403/MUMNP/2005 published 2007-07-20, filed 2005-12-16
The present invention relates to pharmaceutical compositions and more particularly to a pharmaceutical composition containing (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically-acceptable salt thereof as the active ingredient and an inorganic salt in which the cation is multivalent.
Applicant
1)ASTRAZENECA AB
:S-151 85 Sodertalje Sweden
Inventor
1)JOSEPH RICHARD CREEKMORE 2)WIGGINS, Norman, Alfred
International Info
Classification: A61K 31/505
Publication Number: WO/2001/054669
Application Date: 2000-08-04
Priority Information
0001621.1 U.K. 2000-01-26